echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > China's anti-epidemic cooperation with the United Arab Emirates has yielded fruitful results

    China's anti-epidemic cooperation with the United Arab Emirates has yielded fruitful results

    • Last Update: 2021-01-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    2020 is destined to be a year that will be remembered by mankind.
    outbreak of the New Crown in the United States poses a great challenge to human health, socio-economic and global stability.
    good news is that the tireless efforts of mankind have brought the dawn of victory to the war against the epidemic.
    December 9th, the UAE Ministry of Health and Prevention announced that a new crown inactivated vaccine developed by China National Pharmaceutical Group had been approved for sale in the UAE.
    phase III clinical trial analysis showed that the inactivated vaccine against new coronavirus infection effectiveness rate of 86%.
    the vaccine has a 99% serum conversion rate of the meso-antibody and 100% effectiveness in preventing the new coronary to moderate and severe conversion of mild disease.
    , the analysis showed that the vaccine had no serious safety risks.
    uae said the registration of vaccines in China was a major vote of confidence in the safety and effectiveness of the vaccine.
    also marks a solid step forward in protecting public health and preventing the spread of the epidemic.
    in the early days of the outbreak, China faced a severe shortage of medical supplies.
    , China responded quickly and launched an efficient virus resistance campaign to save more lives and protect people's health.
    China quickly dispatched more than 42,000 medical personnel to Wuhan, and adopted the "contact locking, isolation, tracking" model to effectively control the spread of the virus, and rapidly improve medical and testing capabilities to meet epidemic prevention needs.
    these innovative and timely efforts, China has become a leader in global economic recovery in the post-epidemic era, paving the way for epidemic prevention and recovery.
    "In the face of the challenges posed by the new crown pneumonia epidemic, China has achieved a strong economic recovery through active and sound policies, and China is capable of achieving its economic development by 2020, especially in reducing poverty and poverty," said Ali Obeid Al-Zahiri, UAE Ambassador to China, referring to China's rapid recovery.
    is very important to people all over the world."
    , most countries, including the United Arab Emirates, have provided various support for China's fight against the disease.
    uae supports China's response to the pandemic by providing medical supplies, pledging public support and working together on vaccine research and development.
    since the virus first broke out in Wuhan, the UAE has provided China with a wealth of medical necessities, including masks and gloves, to help it through this difficult time.
    January 26, Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and deputy supreme commander of the UAE armed forces, said on social media that the UAE was "confident in the ability of the Chinese government to overcome this crisis".
    uae not only supported China's fight against the disease, but also donated 1,613 tons of much-needed aid to 120 countries and helped 1.6 million medical personnel.
    months, Afghanistan-China cooperation has provided life-saving solutions for both countries, regions and the world.
    close cooperation between China and Afghanistan in the development of new crown vaccines, with a aim to benefit patients around the world.
    uae has played an innovative role in responding to pandemics, with a particular focus on vaccine research and development.
    vaccine research and development has proven to be a particularly successful example of cooperation between the UAE and China.
    the UNITED Arab Emirates technology giant G42 Group, China's state-owned pharmaceutical company, National Pharmaceutical Group, carried out a global phase III trial of the new crown vaccine.
    the new corona inactivated vaccine from The National Pharmaceutical Group has been in the UNITED Arab Emirates since June 23 to launch phase III clinical trials.
    the vaccine was granted emergency use in the Uae in September to protect health care workers fighting on the front lines of the outbreak.
    September 19, the UAE's Minister of Health and Prevention, Abdurrahman Ovis, completed the first vaccination of China's new crown vaccine in the UAE.
    November 3, a number of UAE government officials, including His Highness Sheikh Mohammed bin Rashid Al Maktoum, Chief of Dubai, United Arab Emirates, Vice-President and Prime Minister, were vaccinated against the new crown vaccine developed by China National Pharmaceutical Corporation.
    UAE is also supporting global vaccine delivery.
    Emirates will work with Pfizer to provide the most efficient transportation solution for its new vaccine.
    , the UAE's ambassador to China, Zahiri, said: "The UAE has plans to become China's vaccine supply and logistics center."
    and BioNTech announced that they are developing vaccines that are more than 90 percent effective and could provide much-needed relief to the worst-hit areas of the global epidemic.
    the transportation of vaccines will not only benefit the UAE, but also help the recovery of the Middle East, North Africa and other regions.
    the future, the UAE and China will continue to expand areas of cooperation and build on the achievements made by both sides.
    years, we will strive to expand existing cooperation and create a better future for both peoples.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.